
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem. RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0482 | -4.63461538462 | 1.04 | 1.04 | 0.93885 | 22612 | 0.98471239 | CS |
4 | -0.0382 | -3.70873786408 | 1.03 | 1.09 | 0.8801 | 62699 | 0.98191819 | CS |
12 | -0.2682 | -21.2857142857 | 1.26 | 1.6899 | 0.8801 | 130501 | 1.19771215 | CS |
26 | -0.1682 | -14.5 | 1.16 | 1.6899 | 0.7736 | 91050 | 1.20166109 | CS |
52 | -0.4482 | -31.125 | 1.44 | 1.6899 | 0.7736 | 65865 | 1.19193471 | CS |
156 | -2.2082 | -69.00625 | 3.2 | 5.745 | 0.5306 | 97295 | 2.13521456 | CS |
260 | -7.2582 | -87.9781818182 | 8.25 | 16.74 | 0.5306 | 367770 | 7.43735021 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions